| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
118,790,000 |
| Market
Cap: |
42.71(M) |
| Last
Volume: |
19,275,386 |
Avg
Vol: |
8,983,226 |
| 52
Week Range: |
$0.3595 - $0.3595 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Novavax is a biotechnology company that promotes improved global health through the discovery, development and commercialization of vaccines to prevent serious infectious diseases. Co.'s vaccine candidates, including both its coronavirus vaccine candidate, NVX-CoV2373, and its primary influenza vaccine candidate, NanoFlu, are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. NVX-CoV2373 and NanoFlu include the use of Co.'s proprietary Matrix-M™ adjuvant.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
6,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$43,042 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Modi Rajiv I. |
Director |
– • – |
2014-11-20 |
4 |
S |
$5.02 |
$2,604,823 |
I/I |
(518,889) |
7,500,000 |
|
- |
|
| Modi Rajiv I. |
Director |
– • – |
2014-11-18 |
4 |
S |
$5.01 |
$472,668 |
I/I |
(94,345) |
8,018,889 |
|
- |
|
| Modi Rajiv I. |
Director |
– • – |
2014-11-17 |
4 |
S |
$5.00 |
$6,933,830 |
I/I |
(1,386,766) |
8,113,234 |
|
- |
|
| Phillips Barclay A |
SVP, Chief Financial Officer |
• – – |
2014-10-03 |
4 |
B |
$4.11 |
$20,550 |
D/D |
5,000 |
28,656 |
2.74 |
- |
|
| Hahn Timothy Jon |
SVP, Manufacturing |
• – – |
2014-10-03 |
4 |
B |
$4.05 |
$10,125 |
D/D |
2,500 |
101,156 |
2.74 |
- |
|
| Glenn Gregory M |
SVP, Research and Development |
• – – |
2014-09-26 |
4 |
S |
$4.16 |
$69,929 |
D/D |
(16,809) |
0 |
|
- |
|
| Hahn Timothy Jon |
SVP, Manufacturing |
• – – |
2014-09-25 |
4 |
B |
$4.17 |
$37,530 |
D/D |
9,000 |
98,656 |
2.74 |
- |
|
| Glenn Gregory M |
SVP, Research and Development |
• – – |
2014-07-31 |
4 |
B |
$2.28 |
$28,972 |
D/D |
12,707 |
16,809 |
2.74 |
- |
|
| Herrmann John A Iii |
SVP, General Counsel |
• – – |
2014-07-31 |
4 |
B |
$2.28 |
$20,406 |
D/D |
8,950 |
16,614 |
2.74 |
- |
|
| Hahn Timothy Jon |
SVP, Manufacturing & PD |
• – – |
2014-07-31 |
4 |
B |
$2.28 |
$21,067 |
D/D |
9,240 |
89,656 |
2.74 |
- |
|
| Phillips Barclay A |
SVP, Chief Financial Officer |
• – – |
2014-07-31 |
4 |
B |
$2.28 |
$20,037 |
D/D |
8,788 |
23,656 |
2.74 |
- |
|
| Wilson Russell P |
SVP, Business Development |
• – – |
2014-07-31 |
4 |
B |
$2.28 |
$11,375 |
D/D |
4,989 |
59,889 |
2.74 |
- |
|
| Erck Stanley C |
CEO and President |
• • – |
2014-07-31 |
4 |
B |
$2.28 |
$15,477 |
D/D |
6,788 |
91,656 |
2.81 |
- |
|
| Mcmanus Michael A Jr |
Director |
– • – |
2014-06-17 |
4 |
OE |
$0.56 |
$46,800 |
D/D |
45,000 |
167,590 |
|
- |
|
| Trizzino John |
SVP, Commercial Operations |
• – – |
2014-06-17 |
4 |
B |
$4.51 |
$24,800 |
D/D |
5,500 |
22,000 |
2.74 |
- |
|
| Trizzino John |
SVP, Commercial Operations |
• – – |
2014-06-16 |
4 |
B |
$4.59 |
$25,240 |
D/D |
5,500 |
16,500 |
2.74 |
- |
|
| Trizzino John |
SVP, Commercial Operations |
• – – |
2014-06-13 |
4 |
B |
$4.47 |
$49,214 |
D/D |
11,000 |
11,000 |
2.74 |
- |
|
| Herrmann John A Iii |
SVP, General CounselOfficer |
• – – |
2014-06-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,664 |
|
- |
|
| Erck Stanley C |
CEO and President |
• • – |
2014-03-25 |
4/A |
B |
$4.27 |
$42,698 |
D/D |
10,000 |
84,868 |
2.81 |
- |
|
| Phillips Barclay A |
SVP, Chief Financial Officer |
• – – |
2014-03-25 |
4/A |
B |
$4.25 |
$21,225 |
D/D |
5,000 |
14,868 |
2.74 |
- |
|
| Young James F |
Director |
– • – |
2014-03-25 |
4 |
B |
$4.47 |
$111,837 |
D/D |
25,000 |
425,000 |
2.39 |
- |
|
| Douglas Richard |
Director |
– • – |
2014-03-25 |
4 |
B |
$4.33 |
$216,700 |
D/D |
50,000 |
250,000 |
2.39 |
- |
|
| Phillips Barclay A |
SVP, Chief Financial Officer |
• – – |
2014-03-25 |
4 |
S |
$4.25 |
$21,225 |
D/D |
(5,000) |
14,868 |
|
- |
|
| Erck Stanley C |
CEO and President |
• • – |
2014-03-25 |
4 |
S |
$4.27 |
$42,698 |
D/D |
(10,000) |
84,868 |
|
- |
|
| Modi Rajiv I. |
Director |
– • – |
2014-03-21 |
4 |
S |
$4.69 |
$4,690,000 |
I/I |
(1,000,000) |
9,500,000 |
|
- |
|
155 Records found
|
|
Page 1 of 7 |
|
|
